3,666
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Effect of leukocyte-platelet fibrin-rich wound reconstruction followed by full-thickness skin grafting in the treatment of diabetic foot Wagner grade 4 ulcer gangrene (toe area)

ORCID Icon, , , , &
Article: 2131752 | Received 04 Jun 2022, Accepted 19 Sep 2022, Published online: 10 Oct 2022

References

  • Bandyk DF. The diabetic foot: pathophysiology, evaluation, and treatment. Semin Vasc Surg. 2018;31(2–4):1–7.
  • Zha ML, Cai JY, Chen HL. A bibliometric analysis of global research production pertaining to diabetic foot ulcers in the past ten years. J Foot Ankle Surg. 2019;58(2):253–259.
  • Arıcan G, Kahraman HÇ, Özmeriç A, İ̇ltar S, Alemdaroğlu KB. Monitoring the prognosis of diabetic foot ulcers: predictive value of neutrophil-to-lymphocyte ratio and red blood cell distribution width. Int J Low Extrem Wounds. 2020;19(4):369–376.
  • Engberg S, Kirketerp-Møller K, Ullits Andersen H, Rasmussen A. Incidence and predictors of recurrent and other new diabetic foot ulcers: a retrospective cohort study. Diabet Med. 2019;36(11):1417–1423.
  • Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375.
  • Gordon KA, Lebrun EA, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers. Skinmed. 2012;10(1):24–26.
  • Game FL, Jeffcoate WJ. Dressing and diabetic foot ulcers: a current review of the evidence. Plast Reconstr Surg. 2016;138(3 Suppl):158S–164S.
  • Nather A, Cao S, Chen JLW, Low AY. Prevention of diabetic foot complications. Singapore Med J. 2018;59(6):291–294.
  • Noor S, Khan RU, Ahmad J. Understanding diabetic foot infection and its management. Diabetes Metab Syndr. 2017;11(2):149–156.
  • Robbins JM, Strauss G, Aron D, Long J, Kuba J, Kaplan Y. Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration? J Am Podiatr Med Assoc. 2008;98(6):489–493.
  • Volmer-Thole M, Lobmann R. Neuropathy and diabetic foot syndrome. Int J Mol Sci. 2016;17(6) [Accessed 2016 Jun 10]:[917 p.].
  • Nigi L, Fondelli C, de Donato G, Palasciano G, Setacci C, Dotta F. Fighting diabetic foot ulcers-the diabetologist: a king maker of the fight. Semin Vasc Surg. 2018;31(2–4):49–55.
  • Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K, International Working Group on the Diabetic Foot (IWGDF)Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents. Diabetes Res Clin Pract. 2017;124:84–92.
  • Jhamb S, Vangaveti VN, Malabu UH. Genetic and molecular basis of diabetic foot ulcers: clinical review. J Tissue Viability. 2016;25(4):229–236.
  • Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625.
  • Stefano GB, Challenger S, Kream RM. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders. Eur J Nutr. 2016;55(8):2339–2345.
  • Testa R, Bonfigli AR, Prattichizzo F, La Sala L, De Nigris V, Ceriello A. The “Metabolic Memory” theory and the early treatment of hyperglycemia in prevention of diabetic complications. Nutrients. 2017;9(5) [Published 2017 Apr 28]:[437 p.]. doi: 10.3390/nu9050437.
  • Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JE. Diabetes and advanced glycoxidation end products. Diabetes Care. 2006;29(6):1420–1432.
  • Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003;361(9368):1545–1551.
  • Förstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 2008;5(6):338–349. doi: 10.1038/ncpcardio1211.
  • Andrews KL, Houdek MT, Kiemele LJ. Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine. Prosthet Orthot Int. 2015;39(1):29–39.
  • Ghotaslou R, Memar MY, Alizadeh N. Classification, microbiology and treatment of diabetic foot infections. J Wound Care. 2018;27(7):434–441.
  • Lefrancois T, Mehta K, Sullivan V, Lin S, Glazebrook M. Evidence based review of literature on detriments to healing of diabetic foot ulcers. Foot Ankle Surg. 2017;23(4):215–224.
  • Cam B, Bagdas D, Ozyigit MO, Sagdilek E, Buyukcoskun NI, Ozluk K. Effects of adrenomedullin and glucagon-like peptide on distal flap necrosis and vascularity: the role of receptor systems and nitric oxide. Wounds. 2017;29(6):163–167.
  • Janis J, Harrison B. Wound healing: part II. Clinical applications. Plast Reconstr Surg. 2014;133(3):383e–392e.
  • Philippeos C, Telerman SB, Oulès B, Pisco AO, Shaw TJ, Elgueta R, Lombardi G, Driskell RR, Soldin M, Lynch MD, et al. Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations. J Invest Dermatol. 2018;138(4):811–825.
  • Jeon YR, Kang EH, Yang CE, Yun IS, Lee WJ, Lew DH. The effect of platelet-rich plasma on composite graft survival. Plast Reconstr Surg. 2014;134(2):239–246.
  • Qi M, Zhou Q, Zeng W, Wu L, Zhao S, Chen W, Luo C, Shen M, Zhang J, Tang CE. Growth factors in the pathogenesis of diabetic foot ulcers. Front Biosci (Landmark Ed). 2018;23:310–317.
  • Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018;1411(1):153–165.
  • Gonchar IV, Lipunov AR, Afanasov IM, Larina V, Faller AP, Kibardin AV. Platelet rich plasma and growth factors cocktails for diabetic foot ulcers treatment: state of art developments and future prospects. Diabetes Metab Syndr. 2018;12(2):189–194.
  • Guffanti A. Negative pressure wound therapy in the treatment of diabetic foot ulcers: a systematic review of the literature. J Wound Ostomy Continence Nurs. 2014;41(3):233–237.
  • Stoekenbroek RM, Santema TB, Legemate DA, Ubbink DT, van den Brink A, Koelemay MJ. Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review. Eur J Vasc Endovasc Surg. 2014;47(6):647–655.
  • Blumberg SN, Berger A, Hwang L, Pastar I, Warren SM, Chen W. The role of stem cells in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract. 2012;96(1):1–9.
  • Wang C, Guo M, Zhang N, Wang G. Effectiveness of honey dressing in the treatment of diabetic foot ulcers: a systematic review and meta-analysis. Complement Ther Clin Pract. 2019;34:123–131.
  • Foster JL, McNaughton A. Honey dressings for diabetic foot ulcers: overview of evidence-based practice for novice researchers. Br J Community Nurs. 2020;25(Sup9):S14–19.
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e45–50. doi: 10.1016/j.tripleo.2005.07.009.
  • Kobayashi E, Flückiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, Miron RJ. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig. 2016;20(9):2353–2360.
  • Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors. 2009;27(1):63–69. doi: 10.1080/08977190802636713.
  • He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(5):707–713.
  • Lundquist R, Dziegiel MH, Agren MS. Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin. Wound Repair Regen. 2008;16(3):356–363.